{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:57:36Z","timestamp":1780473456913,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.metabol.2004.05.019","type":"journal-article","created":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T07:18:55Z","timestamp":1108970335000},"page":"314-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"54","author":[{"given":"Hye Seung","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Soo","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Yeol","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Je","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2004.05.019_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.05.019_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2004.05.019_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/oby.2002.1","article-title":"Resistin gene expression in human adipocytes is not related to insulin resistance","volume":"10","author":"Janke","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.metabol.2004.05.019_bib4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1006\/bbrc.2001.6132","article-title":"Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids","volume":"289","author":"Juan","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.metabol.2004.05.019_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1006\/bbrc.2001.6015","article-title":"Decreased resistin expression in mice with different sensitivities to a high-fat diet","volume":"289","author":"Le Lay","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.metabol.2004.05.019_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/bbrc.2001.5173","article-title":"Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle","volume":"285","author":"Nagaev","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.metabol.2004.05.019_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1530\/eje.0.1470571","article-title":"Resistin-a mediator of obesity-associated insulin resistance or an innocent bystander?","volume":"147","author":"Ukkola","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.metabol.2004.05.019_bib8","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","article-title":"Resistin\/Fizz3 expression in relation to obesity and peroxisome proliferator\u2013activated receptor-gamma action in humans","volume":"50","author":"Savage","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2004.05.019_bib9","doi-asserted-by":"crossref","first-page":"25651","DOI":"10.1074\/jbc.C100189200","article-title":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator\u2013activated receptor gamma agonists","volume":"276","author":"Way","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.metabol.2004.05.019_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.metabol.2004.05.019_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/jc.2003-031121","article-title":"Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus","volume":"89","author":"Youn","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.05.019_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cccn.2003.09.009","article-title":"Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes","volume":"339","author":"Fujinami","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.metabol.2004.05.019_bib13","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1210\/jc.2003-030898","article-title":"Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes","volume":"88","author":"McTernan","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.05.019_bib14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1046\/j.1464-5491.2003.01057.x","article-title":"Serum resistin level in essential hypertension patients with different glucose tolerance","volume":"20","author":"Zhang","year":"2003","journal-title":"Diabet. Med."},{"key":"10.1016\/j.metabol.2004.05.019_bib15","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/jc.2002-021808","article-title":"Serum resistin (FIZZ3) protein is increased in obese humans","volume":"88","author":"Degawa-Yamauchi","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.05.019_bib16","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects","volume":"88","author":"Lee","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.05.019_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance","volume":"149","author":"Silha","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.metabol.2004.05.019_bib18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/oby.2003.137","article-title":"Correlation between serum resistin level and adiposity in obese individuals","volume":"11","author":"Azuma","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.metabol.2004.05.019_bib19","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1152\/ajpendo.00457.2002","article-title":"Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation","volume":"285","author":"Moon","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.05.019_bib20","doi-asserted-by":"crossref","first-page":"45209","DOI":"10.1074\/jbc.M304869200","article-title":"Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat","volume":"278","author":"Pravenec","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.metabol.2004.05.019_bib21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.metabol.2004.05.019_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1172\/JCI16521","article-title":"Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production","volume":"111","author":"Rajala","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.metabol.2004.05.019_bib23","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2165\/00003495-200262120-00007","article-title":"Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus","volume":"62","author":"Wagstaff","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2004.05.019_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.metabol.2004.05.019_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.metabol.2004.05.019_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diabetes.52.3.667","article-title":"Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy","volume":"52","author":"Phillips","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2004.05.019_bib27","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.2337\/diabetes.51.10.2968","article-title":"The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects","volume":"51","author":"Yu","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2004.05.019_bib28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.ijo.0802625","article-title":"Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients","volume":"28","author":"Bajaj","year":"2004","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.metabol.2004.05.019_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2004.05.019_bib30","unstructured":"WHO Western Pacific Region. The Asia-Pacific perspective: redefining obesity and its treatment. 2000."},{"key":"10.1016\/j.metabol.2004.05.019_bib31","doi-asserted-by":"crossref","first-page":"19754","DOI":"10.1074\/jbc.M201451200","article-title":"Mechanisms regulating adipocyte expression of resistin","volume":"277","author":"Hartman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.metabol.2004.05.019_bib32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/diabetes.51.6.1737","article-title":"Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells","volume":"51","author":"Shojima","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2004.05.019_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-291X(02)02464-6","article-title":"Effect of metformin on adipose tissue resistin expression in db\/db mice","volume":"298","author":"Fujita","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.metabol.2004.05.019_bib34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/meta.2002.30506","article-title":"Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes","volume":"51","author":"Hirose","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2004.05.019_bib35","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","article-title":"PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein","volume":"50","author":"Maeda","year":"2001","journal-title":"Diabetes"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950400366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604950400366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:55:39Z","timestamp":1758423339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604950400366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S002604950400366X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2004.05.019","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2004.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}